Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: Canada Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20061
20071
20087
20093
20101
20114
20122
20133
20142
20155
20163
20171
20181
20191
20202
20211
20231
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting5
Terminated5
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Novartis Pharmaceuticals5
Celgene3
University Health Network, Toronto3
Jazz Pharmaceuticals2
Kiadis Pharma2
Mirati Therapeutics Inc.2
Toronto Rehabilitation Institute2
University of Manitoba2
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute49
Leukemia12
Myelodysplastic Syndromes12
Myeloproliferative Disorders6
Recurrence6
Hematologic Neoplasms4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia, Myeloid3
Leukemia, Myelomonocytic, Chronic3
Thrombocytopenia3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.